P-piller ger varaktigt skydd mot cancer i äggstockarna: P-pilleranvändning kan förklara minskande förekomst av ovarialcancer i Sverige

Lakartidningen

Volumn 105, Issue 10, 2008, Pages 715-716

  Milsom, Ian ^a   Odlind, Viveca ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; FEMALE; HUMAN; INCIDENCE; MIDDLE AGED; OVARY TUMOR; SHORT SURVEY; SWEDEN;

ADULT; AGED; CONTRACEPTIVES, ORAL; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; OVARIAN NEOPLASMS; SWEDEN;

EID: 41749118302     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (5)

1. Milsom I. Longitudinal studies of birth control and pregnancy outcome among women in an urban Swedish population. In: Glasier A, Wellings K, Critchley H, editors. Contraception and contraceptive use. London: RCOG Press; 2005.
2. Collins J, Crosignani PG, Baird D, Glasier A, Jacobs HS, La Vecchia C, et al. Non contraceptive health benefits of combined oral contraception. Hum Reprod Update. 2005;5:513-25.
3. Cancer and steroid hormone study. The reduction in the risk of ovarian cancer associated with oral contraceptive use. New Engl J Med. 1987;316:650-5.
4. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls. Lancet. 2008;371:303-14.
5. Hannaford PC, Selvaraj S, Elliot AM, Anqus V, Iversen L, Lee AJ. Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study. BMJ. 2007;335:651-8.